menu
    • menu

    Company profile for NRx Pharmaceuticals

    NEW Drugs in Dev: 8
    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    Arlanda is your partner for the Brazil market.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    NRx believes in a world where scientific advancement makes untreatable diseases treatable. We apply our unique clinical and scientific expertise, partnered with leading medical experts, to develop known molecules for medical conditions with no indicated therapies. We are committed to bringing new medicines and hope for people with chronic medical conditions so they may live healthier and more fulfilling lives. The company is b...
    NRx believes in a world where scientific advancement makes untreatable diseases treatable. We apply our unique clinical and scientific expertise, partnered with leading medical experts, to develop known molecules for medical conditions with no indicated therapies. We are committed to bringing new medicines and hope for people with chronic medical conditions so they may live healthier and more fulfilling lives. The company is built upon 30 years of basic science and clinical expertise in understanding the role of the brain’s N-methyl-D-aspartate (NMDA) receptor in regulating human thought processes in general and in regulating depression

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    NRx PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Wilmington, Delaware
    Telephone
    Telephone
    +1 484.254.6134
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.nrxpharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/nrx-pharma
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/NRxPharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    PBP World Meeting

    Not Confirmed

    envelop Contact Supplier

    PBP World Meeting

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    NRx Pharma To Release 2025 Financials And Corporate Update
    NRx Pharma To Release 2025 Financials And Corporate Update

    19 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/19/3258835/0/en/NRx-Pharmaceuticals-Inc-Nasdaq-NRXP-to-Report-Full-Year-2025-Financial-Results-and-Provide-a-Corporate-Update-on-March-24-2026.html

    GLOBENEWSWIRE
    19 Mar 2026
    Share Share
    Nrx Pharma Gets FDA Nod For Preservative-Free Ketamine
    Nrx Pharma Gets FDA Nod For Preservative-Free Ketamine

    17 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/17/3257011/0/en/NRx-Pharmaceuticals-Nasdaq-NRXP-Announces-FDA-Bioequivalence-Determination-by-Office-of-Generic-Drugs-for-NRx-s-Preservative-Free-Ketamine-Application.html

    GLOBENEWSWIRE
    17 Mar 2026
    Share Share
    NRx Pharma Confirms RWD NDA Path for Broader Indication
    NRx Pharma Confirms RWD NDA Path for Broader Indication

    16 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/16/3256130/0/en/NRx-Pharmaceuticals-Nasdaq-NRXP-Confirms-Path-to-New-Drug-Application-with-Real-World-Data-and-Broader-Proposed-Indication-for-NRX-100-ketamine-Following-Type-C-FDA-Meeting.html

    GLOBENEWSWIRE
    16 Mar 2026
    Share Share
    NRx Pharma Names Joshua Brown Chief Medical Innovation Officer
    NRx Pharma Names Joshua Brown Chief Medical Innovation Officer

    02 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/02/3247204/0/en/NRx-Pharmaceuticals-Nasdaq-NRXP-Appoints-Prof-Joshua-Brown-MD-PhD-as-Chief-Medical-Innovation-Officer.html

    GLOBENEWSWIRE
    02 Mar 2026
    Share Share
    NRx Pharma Sets 2025 Annual Meeting Date
    NRx Pharma Sets 2025 Annual Meeting Date

    16 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/16/3220242/0/en/NRx-Pharmaceuticals-Nasdaq-NRXP-Announces-2025-Annual-Meeting-Date-and-Record-Date.html

    GLOBENEWSWIRE
    16 Jan 2026
    Share Share
    NRx Pharma Submits 70K Ketamine Data to FDA for NRX-100 Review
    NRx Pharma Submits 70K Ketamine Data to FDA for NRX-100 Review

    14 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/14/3218507/0/en/NRx-Pharmaceuticals-Nasdaq-NRXP-Announces-70-000-Patient-Data-on-Real-World-Use-of-Ketamine-for-Treatment-of-Suicidal-Depression-to-be-Submitted-to-the-FDA-in-Support-of-NRX-100-Ap.html

    GLOBENEWSWIRE
    14 Jan 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search